ArticleFrontiers in cardiovascular medicine2023

Hypertension, smoking, and preexistence of multiple cardiac risk factors correlate with carfilzomib-induced cardiovascular adverse events in a racially diverse population.

Stacey Doran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.